📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth. (2025)

First Author: Welti J

Attributed to: BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-24-2386

PubMed Identifier: 39787247

Publication URI: http://europepmc.org/abstract/MED/39787247

Type: Journal Article/Review

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

ISSN: 1078-0432